Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse.

Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse.
复制标题

DOI:
10.1113/expphysiol.2012.069831
复制
发表时间:
2013-03
影响因子:
2.7
通讯作者:
Abbate A
Abbate A
中科院分区:
医学4区
文献类型:
--
作者:
Toldo S;Mezzaroma E;Van Tassell BW;Farkas D;Marchetti C;Voelkel NF;Abbate A

文献摘要

参考文献

被引文献

相似文献

The formation of the cryopyrin inflammasome in the heart induces an intense inflammatory response during acute myocardial infarction (AMI), which mediates further damage and promotes adverse cardiac remodeling. Active interleukin-1β (IL-1β) is a key product of the inflammasome, being cleaved by active caspase-1. The aim of this study was to dissect the role of IL-1β from that of the inflammasome by using a neutralizing monoclonal antibody directed against IL-1β and measuring the intensity of the inflammatory response, the activity of caspase-1 in the inflammasome, cardiomyocyte apoptosis, and cardiac remodeling in a mouse model of non-reperfused AMI. A mouse monoclonal IgG2a antibody directed against IL-1β (10 mg/Kg [IL-1β-AB]) was given i.p. immediately after surgery and then repeated 1 week later. Cardiac tissue was analyzed at 72 hours after surgery in a subgroup of mice for inflammasome aggregates and caspase-1 activity (inflammasome) and for DNA fragmentation and caspase-3 activity (apoptosis). All sham-operated mice were alive at 10 weeks, whereas 40% of the control-AB-treated mice and 30% of the IL-1β-AB-treated mice died during the 4 weeks after surgery. When compared with vehicle, treatment with the IL-1β-AB did not affect inflammasome formation or caspase-1 activation in the heart tissue at 72 hours after AMI nor circulating plasma IL-6 levels, but did inhibit cardiomyocyte apoptosis, limit left ventricular enlargement by 40% (P<0.01) and improve systolic dysfunction by 17% (P<0.01) after AMI. These findings suggest that IL-1β mediates the deleterious effects on the heart during sterile inflammatory response.
DOI: 10.1161/circresaha.111.243162
发表时间: 2012-01-06
影响因子: 20.1
作者:
Frangogiannis NG
通讯作者: Frangogiannis NG
DOI: 10.1016/j.cyto.2008.07.004
发表时间: 2008-10
期刊: CYTOKINE
影响因子: 3.8
作者:
Osborn, O.;Brownell, S. E.;Sanchez-Alavez, M.;Salomon, D.;Gram, H.;Bartfai, T.
通讯作者: Bartfai, T.
DOI: 10.2165/11631570-000000000-00000
发表时间: 2012-01-01
期刊: BIODRUGS
影响因子: 6.8
作者:
Abbate, Antonio;Van Tassell, Benjamin W.;Biondi-Zoccai, Giuseppe G. L.
通讯作者: Biondi-Zoccai, Giuseppe G. L.
DOI: 10.1067/s0894-7317(03)00399-7
发表时间: 2003-08-01
影响因子: 6.5
作者:
Broberg, CS;Pantely, GA;Hohimer, AR
通讯作者: Hohimer, AR
DOI: 10.1038/ni.1703
发表时间: 2009-03
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --